SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Elder Pharma targets $ one billion revenue from Japan

02 Feb 2011 Evaluate

Elder Pharmaceuticals is targeting revenues of up to one billion dollars from the lucrative $ 70 billion Japanese pharma market. The company has recently received accreditation from Ministry of Health, Japan for its active pharmaceutical ingredients (API) plant at Patalganga and is planning to be an API and advanced intermediate supplier to the Japanese market.

It has already filed for new patents in these markets and expects the approvals in next six months. The company has also developed two products going off patent in the Japanese market in 2014. One of the products is from the CNS category and the second is from the GI segment. Japan is increasing the share of its healthcare spend on generics pharma and is targeting this share to go up to 30 per cent of its total market by 2013.

Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×